Trials / Completed
CompletedNCT00578929
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,388 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 6 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
A study to demonstrate the superiority of test article nasal spray relative to vehicle nasal spray for the treatment of seasonal allergic rhinitis for a 2 week period in patients aged 6 to 11 years with a history of seasonal allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olopatadine Hydrochloride Nasal Spray 0.6% | Olopatadine HCl 1 or 2 sprays per nostril twice daily |
| DRUG | Vehicle | Vehicle 1 or 2 sprays per nostril twice daily |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2008-11-01
- First posted
- 2007-12-21
- Last updated
- 2010-03-02
- Results posted
- 2010-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00578929. Inclusion in this directory is not an endorsement.